Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease | Pediatrics
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan
PDF) Recurrent lip swelling as a late presentation of Kawasaki disease: Case report and review of literature
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
Kawasaki Disease
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns | BMC Infectious Diseases | Full Text
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan
Frontiers | Antibodies and Immunity During Kawasaki Disease | Cardiovascular Medicine
Clinical and Experimental Pediatrics
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
Clinical Practice Guidelines : Kawasaki disease
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - International Journal of Cardiology
Kawasaki Disease | American Academy of Pediatrics
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
